RxDoctor Payments Data

Divyajot Sandhu, MD

Vascular Neurology · Sioux Falls, SDNPI 1790915973

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Microvention, Inc. accounts for 78.8% of it on its own, with 11 other manufacturers making up the rest.

$14,053in general payments, 2019–2025

Across 143 payments — averaging $98.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$11K
  • Stryker$1K
  • Johnson & Johnson$850
  • Imperative Care, Inc$357
  • Route 92 Medical, Inc.$192
  • Microtransponder, Inc.$164
  • plus $420 from 6 others
$293,494in research payments, 2019–2025

Across 29 payments — averaging $10,120 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$293K

What the payments were for

  • Consulting fees$1,50011%
  • Travel & lodging$6,18044%
  • Food & beverage$6,37245%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$119,810
Medicare patients
222
Services billed
725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor13$4,187
ClopidogrelClopidogrel Bisulfate29$171
Oxcarbazepine13$147
Atorvastatin Calcium12$37

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Sioux Falls

Where these figures come from

Is this you, or does something look wrong? →